September 13, 2023
CHEONAN, South Korea -- MGI, a company committed to building core tools and technology to lead life science, today announced MOU with Bio-Medical Science Co., Ltd. ("BMS") to expand genomics solutions in South Korea by leveraging MGI's cutting-edge technology. The MOU is expected to reach collaborations in localizing MGI's manufacturing capability in selected genetic sequencers and reagents in South Korea via [...]
September 13, 2023
As a part of the National Institute of Standards and Technology (NIST) Genome Editing Consortium, BioSkryb will help enable increased confidence in gene edited research and commercial products DURHAM, N.C. -- BioSkryb Genomics, a company transforming single-cell analysis by enabling the most complete multiomic view of the cellular ecosystem, from discovery to diagnostics, today announced [...]
September 13, 2023
BOSTON -- Curiox Biosystems, a global leader in providing innovative and automated sample preparation solutions for accurate and reproducible cell analysis, is pleased to announce its collaboration with Dr. Marco Ruella, an Assistant Professor of Medicine at the Perelman School of Medicine at the University of Pennsylvania (Penn), to support efforts in the development of next-generation cancer cell therapies. https://www.youtube.com/watch?v=2AF8nyanzc4 The collaboration [...]
Willkie Advises Qualium Investissement and Lauxera Capital Partners in Acquisition of VERDOT
September 13, 2023
On September 13, Willkie clients Qualium Investissement and Lauxera Capital Partners announced their acquisition of a majority stake in VERDOT, a leading provider of chromatographic purification solutions. Qualium Investissement and Lauxera Capital Partners acquired a majority stake in VERDOT through an investment of over €65 million, alongside the company’s management team and existing shareholders Capital [...]
September 12, 2023
UPPSALA, Sweden -- Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced the collaboration with Eurofins Genomics to bolster its offerings in the fields of research, population health, and regulated clinical trials through the application of Olink technology. The Olink platform represents the cutting edge in proteomics technology, delivering exceptional sensitivity and specificity for protein biomarker [...]
September 12, 2023
ROCKVILLE, Md. -- Multiomics CRO Psomagen is thrilled to announce the launch of Spatial Biology services for 10X Genomics Xenium™. This platform is reshaping spatial biology, enabling researchers worldwide to analyze the interplay of genes and proteins within their native tissue context. This marks a pivotal moment in the scientific community's access to spatial genomics. According to Psomagen [...]
LAXAI Life Sciences Selects CDD Vault for Digital Transformation
September 12, 2023
Hyderabad and San Francisco - LAXAI Life Sciences, a leading Contract Research, Development, and Manufacturing Organization (CRDMO), has announced the adoption of the CDD Vault informatics platform. This strategic move underscores LAXAI’s commitment to combining science and innovation, reinforcing its clients’ competitive advantage through high-quality, efficient services. Krishna Kishore RV, EVP-Integrated Drug Discovery at Laxai, [...]
Torx® Software announces global drug discovery collaboration with CDD Vault®
September 12, 2023
Cambridge, UK - Torx® Software Limited announces a collaboration with CDD Vault to facilitate the seamless synthesis and registration of new compounds during the small-molecule drug discovery process. Torx, is a cloud-based platform developed by Cresset and Elixir™ Software which enables chemistry teams to collaborate, design molecules and track compound synthesis across the design-make-test-analyze (DMTA) [...]
Cytiva expands scientific, digital, and training offering in China
September 12, 2023
The facility will host training for more than triple the current number of people per year. The upgraded Fast Trak center will support novel therapy development and help address the regional talent gap. Designed to meet the specific needs of customers in China Recognizing the long-term needs of the biopharma industry in China and Asia-Pacific, [...]
September 12, 2023
Caption: (Left) Pyrophosphatase (inorganic), HQ; (Right) T7 RNA Polymerase, HQ. Saint-Germain-en-Laye, France – Takara Bio Europe (TBE) announced today the launch of new High Quality (HQ) grade mRNA production enzymes "T7 RNA polymerase, HQ" and "Pyrophosphatase (inorganic), HQ" suitable for pre-clinical and process development in mRNA vaccine and therapeutic manufacturing. HQ grade enzymes have features [...]

